Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02614170 · ClinicalTrials.gov registry record
A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Insulin in Healthy Individuals
A clinical trial, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 328
- Enrollment target
NCT02614170 is a clinical trial that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 328 participants.
The verdict
NCT02614170 has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 328 participants
- Enrollment target
Study Summary
The study objectives are described below: 1. Obtain matched serum, plasma \[(K2 EDTA, Sodium Heparin (NaH), Lithium Heparin (LiH)\] and urine specimens collected from a minimum of 50 healthy subjects. Specimens will be used to determine a reference range for C-peptide and insulin assays, used as an aid in the assessment of C-peptide and insulin in adults. 2. Obtain serum and urine specimens collected from a minimum of an additional 200 healthy subjects. Specimens will be used to determine a reference range for C-peptide and insulin assays, used as an aid in the assessment of C-peptide and insulin in adults. 3. To store any remaining specimens for use in future assay development and to evaluate as yet undetermined assays for the development of IVDs, including additional C-peptide or insulin assays.
Interventions
- OTHER Prospective Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02614170
The ClinicalTrials.gov registry entry for NCT02614170 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujirebio Diagnostics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prospective Blood Draw is the first listed.
NCT02614170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02614170 about?
NCT02614170 is a clinical study titled "A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Insulin in Healthy Individuals". The study objectives are described below: 1. Obtain matched serum, plasma \[(K2 EDTA, Sodium Heparin (NaH), Lithium Heparin (LiH)\] and urine specimens collected from a minimum of 50 healthy subjects. Specimens will be used to determine a reference range for C-peptide and insulin assays, used as an...
What is the current status of trial NCT02614170?
This trial is currently completed. The enrollment target is 328 participants. The study started on 2015-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02614170?
The interventions under investigation include: Prospective Blood Draw (OTHER).
Who is sponsoring clinical trial NCT02614170?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.